Public Profile

Organogenesis Holdings Inc.

Organogenesis Holdings Inc., a leading player in the regenerative medicine sector, is headquartered in the United States. Founded in 1985, the company has established itself as a pioneer in advanced wound care and surgical biologics, focusing on innovative solutions that enhance healing and improve patient outcomes. With a strong presence across North America, Organogenesis offers a diverse portfolio of products, including allograft and xenograft tissue products, which are distinguished by their unique biological properties and effectiveness. The company has achieved significant milestones, including FDA approvals for several of its key offerings, solidifying its position in the market. Recognised for its commitment to quality and innovation, Organogenesis continues to lead the way in transforming patient care through its cutting-edge therapies and comprehensive support services.

DitchCarbon Score

How does Organogenesis Holdings Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Organogenesis Holdings Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

Organogenesis Holdings Inc.'s reported carbon emissions

Organogenesis Holdings Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing greenhouse gas emissions. As the company operates within the regenerative medicine industry, it may face increasing pressure to establish and communicate its climate strategies in line with global sustainability trends.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Organogenesis Holdings Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Organogenesis Holdings Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Organogenesis Holdings Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Shire plc

IE
Health and social work services (85)
Updated 5 days ago
DitchCarbon Score

Tissue Regenix Group plc

GB
Health and social work services (85)
Updated 2 days ago

RegenETP, Inc.

US
Health and social work services (85)
Updated 2 days ago

Acelity L.P. Inc.

US
Health and social work services (85)
Updated 5 days ago

CollPlant

IL
Other business services (74)
Updated 2 days ago

Shire Regenerative Medicine, Inc.

US
Health and social work services (85)
Updated 5 days ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers